Devic disease, also known as neuromyelitis optica (NMO), is an autoimmune disease of the central nervous system that primarily affects the spinal cord and optic nerves. It was first described in 1870 by the French neurologist Eugène Devic and since then it has been the subject of study and research in the field of neurology. This rare disease can have a significant impact on the quality of life of those who suffer from it, so it is important to understand its symptoms, causes and treatment options.

Symptoms of Devic's disease

Devic's disease is mainly characterized by inflammation of the spinal cord and optic nerves. Symptoms of the disease can vary from person to person, but the most common include:

1. Visual disturbances:

Eye problems are often one of the first symptoms of Devic disease. Patients may experience blurred vision, loss of vision in one or both eyes, double vision, eye pain, and abnormal eye movements.

2. Neurological disorders:

Neurological symptoms may include muscle weakness, muscle spasms, difficulty moving the arms or legs, problems with balance and coordination, numbness or tingling in the extremities, and pain in the neck or head. back.

3. Urinary tract and intestinal problems:

Patients with Devic disease may also experience problems related to urination and defecation, such as urinary incontinence, urinary urgency, constipation, or fecal incontinence.

4. Fatigue and generalized weakness:

Severe fatigue and generalized weakness are common symptoms in people with Devic disease, which can negatively affect their ability to perform daily activities and lead a normal life.

5. Neuropathic pain:

Neuropathic pain, commonly described as stabbing, burning, or electrical shock-like, can affect patients with Devic disease and cause significant discomfort.

Causes of Devic's Disease

Devic's disease is recognized as an autoimmune disease, meaning that the body's immune system mistakenly attacks its own healthy tissues. In the case of NMO, the immune system attacks myelin, a substance that covers and protects nerve fibers in the brain and spinal cord. This inflammation destroys myelin and damages nerve fibers, causing the characteristic symptoms of the disease.

It is believed that genetic and environmental factors may play a role in the development of Devic disease. Some studies have suggested that certain genetic variations may increase a person's susceptibility to developing NMO. Additionally, environmental factors such as viral infections, exposure to toxins, and other triggers can trigger the autoimmune response in predisposed individuals.

Diagnosis of Devic disease

Diagnosis of Devic disease It can be challenging due to the similarity of its symptoms to other neurological diseases, such as multiple sclerosis. The neurology doctor will carry out a thorough evaluation that may include:

1. Clinical history:

The doctor will review the patient's symptoms, medical history, and family history to evaluate the presence of risk factors or previous autoimmune diseases.

2. Neurological examination:

A detailed physical examination will be performed to evaluate neurological function, including vision, muscle strength, reflexes, sensation, and coordination.

3. Imaging tests:

Magnetic resonance (MRI) tests can show characteristic lesions in the spinal cord and optic nerves that are indicative of Devic disease.

4 . Cerebrospinal fluid analysis:

A lumbar puncture may be performed to test the cerebrospinal fluid for signs of inflammation or the presence of certain proteins associated with Devic disease.

Treatment of Devic disease

Treatment of Devic disease focuses on controlling symptoms, preventing relapses, and reducing inflammation to limit damage to the central nervous system. Some of the treatment options include:

1. Corticosteroid therapy:

Corticosteroids, such as prednisone, are commonly used to reduce inflammation in the nervous system and control disease flares. However, long-term use may be associated with significant side effects.

2. Immunosuppressive treatment:

Immunosuppressive medications, such as rituximab or azathioprine, can help prevent autoimmune attacks and reduce the frequency of relapses in patients with Devic disease.

3. Plasmapheresis:

Plasmapheresis is a procedure in which a portion of the patient's blood plasma is removed and replaced to eliminate autoimmune antibodies that are causing inflammation in NMO.

4. Rehabilitation therapy:

Physical, occupational, and speech therapy can help patients regain function and mobility lost due to Devic disease, thereby improving their quality of life.

5. Symptomatic management:

Symptomatic treatment of visual problems, urinary tract problems, and other associated symptoms may be necessary to improve the general well-being of patients with Devic disease.

Conclusions

In summary, Devic disease is an autoimmune condition of the central nervous system that primarily affects the spinal cord and optic nerves. Its symptoms can vary in severity and presentation, but visual and neurological problems are common among patients. Early diagnosis and a comprehensive therapeutic approach are essential to control the progression of the disease and improve the quality of life of those who suffer from it.

More research is needed to better understand the underlying causes of Devic disease. and develop more effective and personalized treatments for patients. Supporting research and raising awareness about this rare disease is essential to improve access to specialized medical care and ensure a better quality of life for those living with NMO.